Acquisition Announced Sponsor buyer

Teva Pharmaceuticals acquisition of Emalex Biosciences

US$700m consideration

Announced 29 Apr 2026

Advisers

Emalex Biosciences

Target

Financial adviser
PHCP

Teva Pharmaceuticals

Acquirer

Financial adviser
Target
Emalex Biosciences
Acquirer
Teva Pharmaceuticals
Sponsor
Teva Pharmaceutical Industries
Target based in
United States
Buyer based in
United States
Sector
Pharma
Tags
Pharma, Biotech

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.